Synergistic induction of eotaxin expression in human keratocytes by TNF- α and IL-4 or IL-13

Investigative Ophthalmology and Visual Science

Volumn 41, Issue 6, 2000, Pages 1448-1453

  Kumagai, Naoki ^a   Fukuda, Ken ^b   Ishimura, Yoshitsugu ^b   Nishida, Teruo ^b  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EOTAXIN; INTERLEUKIN 13; INTERLEUKIN 4; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL LYSATE; CORNEA CELL; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; AGED; CELLS, CULTURED; CHEMOKINES, CC; CHEMOTACTIC FACTORS, EOSINOPHIL; CHILD; CHILD, PRESCHOOL; CORNEA; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG SYNERGISM; FEMALE; FIBROBLASTS; HUMANS; INTERLEUKIN-13; INTERLEUKIN-4; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034057709     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Trocme SD, Kephart GM, Allansmith MR, Bourne WM, Gleich GJ. Conjunctival deposition of eosinophil granule major basic protein in vernal keratoconjunctivitis and contact lens-associated giant papillary conjunctivitis. Am J Ophthalmol. 1989;108:57-63.
2. Trocmé SD, Hallberg CK, Gill KS, et al. Effects of eosinophil granule proteins on human corneal epithelial cell viability and morphology. Invest Ophthalmol Vis Sci. 1997;38:593-599.
3. Griffiths-Johnson DA, Collins PD, Rossi AG, Jose PJ, Williams TJ. The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo. Biochem Biophys Res Commun. 1993;197:1167-1172.
4. Takafuji S, Shoji S, Ito K, Yamamoto K, Nakagawa T. Eosinophil degranulation in the presence of lung fibroblasts. Int Arch Allergy Immunol. 1998;117(suppl 1):52-54.
5. Maggi E, Biswas P, Del Prete G, et al. Accumulation of Th-2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis. J Immunol. 1991;146:1169-1174.
6. Bradding P, Mediwake R, Feather IH, et al. TNF α is localized to nasal mucosal mast cells and is released in acute allergic rhinitis. Clin Exp Allergy. 1995;25:406-415.
7. Gauchat JF, Lebman DA, Coffman RL, Gascan H, de Vries JE. Structure and expression of germline ∈ transcripts in human B cells induced by interleukin 4 to switch to IgE production. J Exp Med. 1990;172:463-473.
8. Fujishima H, Takeuchi T, Shinozaki N, Saito I, Tsubota K. Measurement of IL-4 in tears of patients with seasonal allergic conjunctivitis and vernal keratoconjunctivitis. Clin Exp Immunol. 1995; 102:395-398.
9. Leonardi A, Borghesan F, DePaoli M, Plebani M, Secchi AG. Procollagens and inflammatory cytokine concentrations in tarsal and limbal vernal keratoconjunctivitis. Exp Eye Res. 1998;67:105-112.
10. de Vries JE. The role of IL-13 and its receptor in allergy and inflammatory responses. J Allergy Clin Immunol. 1998;102:165-169.
11. Huang SK, Xiao HQ, Kleine-Tebbe J, et al. IL-13 expression at the sites of allergen challenge in patients with asthma. J Immunol. 1995;155:2688-2694.
12. Cubitt CL. Tang Q, Monteiro CA, Lausch RN, Oakes JE IL-8 gene expression in cultures of human corneal epithelial cells and keratocytes. Infest Ophthalmol Vis Sci. 1993;34:3199-3206.
13. Tran MT, Tellaetxe-Isusi M, Elner V, et al. Proinflammatory cytokines induce RANTES and MCP-1 synthesis in human corneal keratocytes but not in corneal epithelial cells. β-chemokine synthesis in corneal cells. Invest Ophthalmol Vis Sci. 1996;37:987-996.
14. Mishima H, Yasuimoto K, Nishida T, Otori T. Fibronectin enhances the phagocytic activity of cultured rabbit keratocytes. Invest Ophthalmol Vis Sci. 1987;28:1521-1526.
15. Garcia-Zepeda EA, Rothenberg ME, Ownbey RT, et al. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat Med. 1996;2:449-456.
16. Fini ME, Girard MT, Matsubara M. Bartlett JD. Unique regulation of the matrix metalloproteinase, gelatinase B. Invest Ophthalmol Vis Sci. 1995;36:622-633.
17. Ohashi H, Maeda T, Mishima H, et al Up-regulation of integrin α5β1 expression by interleukin-6 in rabbit corneal epithelial cells. Exp Cell Res. 1995;218:418-423.
18. Mochizuki M, Bartels J, Mallet AI, Christophers E, Schröder JM. IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy. J Immunol. 1998; 160:60-68.
19. Brenner MK. Tumour necrosis factor. Br J Haematol. 1988;69: 149-152.
20. Ishizaka K. Basic mechanisms of IgE-mediated hypersensitivity. Curr Opin Immunol. 1989;1:625-629.
21. Jose PJ, Adcock IM, Griffiths-Johnson DA, et al. Eotaxin: cloning of an eosinophil chemoattractant cytokine and increased mRNA expression in allergen-challenged guinea-pig lungs. Biochem Biophys Res Commun. 1994;205:788-794.
22. Zhu Z, Homer RJ, Wang Z, et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest. 1999;103:779-788.
23. Hohki G, Terada N, Haniano N, et al. The effects of eotaxin on the surface adhesion molecules of endothelial cells and on eosinophil adhesion to microvascular endothelial cells. Biochem Biophys Res Commun. 1997;241:136-141.
24. Burke-Gaffney A, Hellewell PG. A CD18/ICAM-1-dependent pathway mediates eosinophil adhesion to human bronchial epithelial cells. Am J Respir Cell Mol Biol. 1998;19:408-418.
25. El-Shazly A, Masuyama K, Nakano K. et al. Human eotaxin induces eosinophil-derived neurotoxin release from normal human eosinophils. Int Arch Allergy Immunol. 1998;117(suppl 1)55-58.